coa mixture; the newly branded coa fs
TRANSCRIPT
COA MIXTURE; THE NEWLY BRANDED COA FS
1COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations
. . . SAME HERBAL & NATURAL BLEND OF LEAVES
INTRODUCTION
➢Medicinal plants have long been known as sources ofdrugs.
➢The use of natural products with therapeuticproperties is as ancient as human civilisation and, fora long time, minerals, plants and animal productswere the main sources of drugs (De Pasquale, 1984).
➢Of the 252 drugs considered as basic and essential bythe World Health Organisation (WHO), 11% areexclusively of plant origin and a significant number aresynthetic drugs obtained from natural precursors(Rates, 2001).
COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations 2
➢Recent developments in the field of traditionalmedicine have resulted in the production ofimproved herbal products using technologicallyadvanced production processes.
➢The COA Mixture® (formerly sold under the tradename COA FS®) is a potent plant extract for generalwellbeing.
➢ It is a dietary supplement which is taken orally andhas been scientifically prepared to support theHuman Immune System.
➢ It helps to fight naturally, a variety of deadly diseases.
COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations 3
COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations
4
THE COA RESEARCH AND MANUFACTURING COMPANAY LTD
COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations 5
FDA APPROVED AND STATE-OF-THE-ART FACILITY
The Factory
➢ WHO current Good Manufacturing Process compliant
➢ Implementation of ISO 9001-2015 Quality Management System
➢ Health and Fire Safety Certified ➢ Semi-Automated production facility➢ Uses Reverse Osmosis purified water in the
production process (the only herbal product manufacturing company in Ghana to have installed this equipment)
➢ Highly skilled and experienced staff ➢ Environmentally friendly practices
6COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations
COA MIXTURE➢Is a free-flowing colourless liquid with a fruity smell.
➢Made from six natural and potent herbs; 100% Herbal and Natural.
➢Contains over 161 organic compounds identified (Boadu et al., 2018).➢alkaloids, anthraquinones, saponins, flavonoids, tannins, terpenoids,
glycosides, octadecanoic acid, phytol acetate, pentadecanoic acid, heneicosane, eicosane, hexadecanamide, octadecanamide, 2-methylytetracosane, triterpenes.
➢Is one of the few herbal products on the market with no added artificial preservatives
➢Has been scientifically tested and confirmed to be;➢Microbiologically safe➢Non toxic to the liver and kidneys in both acute and chronic toxicity tests
➢Supports GENERAL WELL BEING of the body and can be used to support treatment and for management of all disease conditions.
COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations 7
Constituents of COA Mixture and their therapeutic indications
Item Plant Selected Therapeutic indication
1 Azadirachta indica Diabetes mellitus, diarrhoea, dysentery, fever, hepatitis, , hypertension, jaundice,
2 Ocimum veride Chronic catarrh, asthma, convulsion, colic, indigestion
3 Spondias mombin Intestinal worms and parasites, menstrual disorders (pain, cramps and irregularity), vaginal infections and yeast infections.
4 Vernonia amygdalina Asthma; bacterial and fungal skin disorders; diabetes; fever; headaches, malaria, ringworm; upper respiratory tract infections
5 Persea americana High blood pressure, liver problems, gout, aphrodisiac
6 Carica papaya Colitis, dysentery, hypertension, intestinal helminthiasis, urinary retention
Refs1. Ayensu, E. S. (1978). Medicinal Plants of West Africa. Reference Publications, Inc., 218 St. Clair River Drive, Algonac, Michigan 48001, USA.2. Antia B S, Okokon J E, Okon P A. Hypoglycemic activity of aqueous leaf extract of Persea americana Mill. Indian J Pharmacol [serial online] 2005 [cited 2020 Oct 26];37:325-6. Available from: https://www.ijp-online.com/text.asp?2005/37/5/325/168583. West African Herbal Pharmacopoeia (2013) West African Health Organisation BOBO-DIOULASSO BURKINA FASO
8COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations
COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations
9
The COA Mixture® increases CD4 count and improves immune function, and is registered
as an herbal product for general wellbeing by the Food and Drugs Authority, Ghana.
OLD PACKAGING Features
➢ Packaged in 250 mL white HDPE bottle with a white inlet and a blue cap.
10COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations
NEW PACKAGING Features
COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations 11
• Aluminium foil
• Customised “COA” bottle
• Cellulose paper in cap
12
CONDITIONAL (Dependent onDoctor’s advice)
MIX 20 mL OF COA MIXTUREWITH 50 mL WARM WATER.
STANDARD (When used as asupplement)
MIX 10 mL OF COA MIXTURE WITH 50mL WARM WATER.
➢ TAKE IT IMMEDIATELY.➢ ALLOW AN HOUR BEFORE MEALS OR OTHER MEDICATIONS.➢ REPEAT DOSE AFTER 12 HOURS.COA Research and Manufacturing Company
Limited _Excellence in Clinical Innovations
Reports and Publications on COA MIXTURE (formerly CoA FS)
13COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations
COA FS (now COA Mixture) caused a decrease in viral load in HIV patients. (A report by Ocloo et al., 2018)
0
50000
100000
150000
200000
250000
300000
350000
Before After
Me
an v
iral
load
(co
pie
s/m
l)
COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations
14
COA FS (now COA Mixture caused a significant decrease in Hep B DNA in patients (p = 0.002). (A report by Ocloo et al., 2018)
0
200
400
600
800
1000
1200
1400
1600
Before After
Mea
n H
ep B
Vir
us
DN
A (
IU/m
l)
*
COA FS (now COA Mixture) exhibited high potency against LNCap cell line (a blood cancer cell line) (Languon et al., 2018: Journal of evidence-based integrative medicine, 23, 2515690X18790723).
COA FS (now COA Mixture) exhibited high potency against Jurkat cell line (a blood cancer cell line) (Languon et al., 2018: Journal of evidence-based integrative medicine, 23, 2515690X18790723).
Phytochemical analysis using GC-MS confirmed Vernonia Amygdalina (Bitter leaf) and Persea Americana (Avocado) as constituent plants of COA FS (now COA Mixture). (Thesis by Kwasi Boadu, 2018_https://researchspace.ukzn.ac.za/handle/10413/18030)
Conclusion: Major phytochemicals including heneicosane, phytyl acetate, pyrene, octadecanoic acid, eicosane, 2-methyltetracosane, pentadecanoic acid, hexadecanamide, and octadecanamide were identified in COA Mixture
18COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations
Nonclinical Pharmacokinetics and Product Metabolism
• A computational analysis of COA Mixture® (COA FS®) revealed that some PIs that are currently in use showed inhibitory activities on CYP3A4.
• Seven of the phytochemical compounds present in the COA Mixture® were also predicted to possess inhibitory activity on CYP3A4.
• The inhibition of CYP3A4 by the phytochemical compound could decrease the elimination and pumping out of the four PI drugs from the systemic circulation and the cells respectively thereby increasing the effectiveness of the PI drugs (Kehinde et al., 2019).
COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations 19
“NATURAL” INSIGHTS INTO PHARMACOKINETIC PROPERTIES AND HIV-1
INHIBITORS: A COMPUTATIONAL AND IN VITRO PERSPECTIVES ON COA®-FS
HERBAL MEDICINE PHYTOCHEMICAL COMPOUNDS.
Idowu Kehindea, Pritika Ramharackb, Mahmoud E. S. Solimanb, Manibulu Nlootob*, Michelle Gordona
COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations
The result also showed the drug likeness of four FDA-approved ARV drugs and fifteen
selected phytochemical compounds from COA Mixture®. Two of the four conventional
drugs and nine of the phyto-chemical compounds passed the drug likeness test. These
showed that the nine phytochemical compounds have good drug properties as seen in the
two conventional drugs (Kehinde et al., 2019).
20
COA Research and Manufacturing Company Limited _Excellence in Clinical Innovations21
THANK YOU